Authors


Kavita Patel, MD, MS

Latest:

Transforming Oncology Care: Payment and Delivery Reform for Person-Centered Care

The authors examine 4 alternative payment models for oncology care that shift away from fee-for-service and move progressively toward greater bundling, either across providers or across payments.




Thomas Seck, MD

Latest:

Compliance and Persistence With Concomitant Statin and Oral Antihyperglycemic Therapy

In patients with type 2 diabetes, compliance and persistence were generally low for both statin and antihyperglycemic therapy, but they were significantly lower with statin therapy.






Veena Shankaran, MD, MS

Latest:

Assessing Surveillance Utilization and Value in Commercially Insured Patients With Colorectal Cancer

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but higher costs.


Carey C. Thomson, MD, MPH

Latest:

Thirty-Day Readmissions: Relationship to Physician Attending Type and Social Connectedness

This study examined patient clinical and demographic characteristics, healthcare system factors, and patients’ experiences of care associated with 30-day readmissions in a hospital with a Pioneer Accountable Care Organization.


Evan A. DeZeeuw, PharmD

Latest:

Impact of Telephonic Comprehensive Medication Reviews on Patient Outcomes

Discussion of current literature regarding the impact of telephonically delivered comprehensive medication reviews on patient outcomes, including mortality rates, hospital readmission rates, and healthcare expenditures.


Lindsay Kindler, PhD, RN

Latest:

Acupuncture and Chiropractic Care: Utilization and Electronic Medical Record Capture

Most patients with chronic musculoskeletal pain use acupuncture or chiropractic care. A substantial percentage of this utilization, however, is not captured by the electronic medical record.


Thaddeus Grasela, PharmD, PhD

Latest:

Individual Treatment Effects: Implications for Research, Clinical Practice, and Policy

A framework for researchers, providers, payers, or public health bodies identifies when it is most critical to distinguish between "average" population and individual patient response.


Benjamin Eng, MD

Latest:

Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs

Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.


Shivani Sampathkumar, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.



Deborah Taira Juarez, ScD

Latest:

Factors Affecting Medication Adherence Trajectories for Patients With Heart Failure

Nonwhite race, smoking, and increasing body mass index were associated with the lowest adherence trajectories for patients with heart failure, with adherence dropping off within the first year.


John Schulz, BA

Latest:

Medicare Shared Savings Program: Public Reporting and Shared Savings Distributions

Analysis of publicly reported organizational characteristics, shared savings distribution plans, and early financial success of accountable care organizations in the Medicare Shared Savings Program.


Bruce Barth

Latest:

Charitable Assistance Among Economically Vulnerable Cancer Patients: Patient Access Network Foundation Summary Statistics 2011-2015

This report shows that among people who are eligible for charitable assistance to cover out-of-pocket (OOP) prescription drug expenses, those with cancer have higher per-claim and per-person OOP costs than their counterparts with other health conditions.



Nate Brown, BA

Latest:

A Step in the Digital Direction: From Paper Logs to Electronic Data Capture

Research documentation is a critical aspect of running a clinical trial. Key patient information such as informed consent, adverse events (AEs), concomitant medications, and medical and surgical histories are collected and used to determine patient safety and efficacy as the trial proceeds. Ultimately, the sponsor may make decisions—ranging from modifying the dose of the investigational drug to closing the study due to AEs—based on the data collected.





Dawn Weddle, RD

Latest:

Food as Medicine: Impact on Diabetes Management

This article addresses what employers need to know about food as medicine and offers practical steps to reduce barriers for their employee populations.


Sarah Muench, PharmD

Latest:

Impact of a Pharmacist-Managed Diabetes Clinic on Quality Measures

This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)



Amer Budayr, MD

Latest:

Trends in Mortality Following Hip Fracture in Older Women

Within an integrated healthcare setting, temporal trends demonstrate reductions in mortality risk after hip fracture in older women, with mortality risk lower for Asians and Hispanics.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo